NovaRock Biotherapeutics, Ltd clinical trials
A subsidiary of CSPC Pharmaceutical Group Limited
The registry lists 4 studies whose lead sponsor is NovaRock Biotherapeutics, Ltd. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 26, 2024.
Registry sponsor names on this page
- NovaRock Biotherapeutics, Ltd4 studies
Something wrong with this grouping? Tell us on the CSPC Pharmaceutical Group Limited page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All CSPC Pharmaceutical Group Limited studies →
- A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.RecruitingNCT05877924Phase 1
Sponsor listed in the registry: NovaRock Biotherapeutics, Ltd
- A Study of NBL-028 in Patients With Advanced Solid TumorsRecruitingNCT06223256Phase 1
Sponsor listed in the registry: NovaRock Biotherapeutics, Ltd
- Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid TumorsNot yet recruitingNCT05153096Phase 1
Sponsor listed in the registry: NovaRock Biotherapeutics, Ltd
- A Study of NBL-012 in Healthy Chinese SubjectsCompletedNCT05259189Phase 1
Sponsor listed in the registry: NovaRock Biotherapeutics, Ltd